Imaging gene delivery with fluorescence microscopy

Nanomedicine

Volumn 2, Issue 6, 2007, Pages 847-860

  Payne, Christine K ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Fluorescence microscopy; Gene delivery; Polyethylenimine; Single particle tracking; Synthetic vectors

Indexed keywords

CAVEOLIN; CHLORPROMAZINE; CLATHRIN; DNA; FILIPIN; FLUORESCEIN ISOTHIOCYANATE; LIPOFECTAMINE; POLYETHYLENEIMINE; POLYLYSINE; POLYMER; PROTEOGLYCAN; QUANTUM DOT; SMALL INTERFERING RNA; TETRAMETHYLRHODAMINE METHYL ESTER;

AUTOFLUORESCENCE; CELL CULTURE; CELL LABELING; CELL MEMBRANE PERMEABILITY; CELL NUCLEUS; CELL TRANSPORT; CELLULAR DISTRIBUTION; COMPLEX FORMATION; DNA BINDING; DRUG MECHANISM; ENDOCYTOSIS; ENDOSOME; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPE; FLUORESCENCE MICROSCOPY; GENE DELIVERY SYSTEM; GENE THERAPY; GENE VECTOR; GENETIC TRANSFECTION; HUMAN; IMAGE ANALYSIS; INHIBITION KINETICS; INTERNALIZATION; LYSOSOME; NEODYMIUM LASER; PRIORITY JOURNAL; REVIEW; TRANSPORT KINETICS;

GENE EXPRESSION PROFILING; GENE TARGETING; GENE TRANSFER TECHNIQUES; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MICROSCOPY, FLUORESCENCE;

EID: 38049129633     PISSN: 17435889     EISSN: None     Source Type: Journal    
DOI: 10.2217/17435889.2.6.847     Document Type: Review

References (118)

1. Lee TWR, Matthews DA, Blair GE: Novel molecular approaches to cystic fibrosis gene therapy. Biochem. J. 387, 1-15 (2005).
2. Ferrari S, Geddes DM, Alton E: Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis. Adv. Drug Deliv. Rev. 54, 1373-1393 (2002).
3. Koehler DR, Hitt MM, Hu J: Challenges and strategies for cystic fibrosis lung gene therapy. Mol. Ther. 4, 84-91 (2001).
4. Costantini LC, Bakowska JC, Breakefield XO, Isacson O: Gene therapy in the CNS. Gene Ther. 7, 93-109 (2000).
5. El-Aneed A: An overview of current delivery systems in cancer gene therapy. J. Control. Release 94, 1-14 (2004).
6. Verma IM, Weitzman MD: Gene therapy: twenty-first century medicine. Ann. Rev. Biochem. 74, 711-738 (2005).
7. Lechardeur D, Sohn KJ, Haardt M et al.: Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer. Gene Ther. 6, 482-497 (1999).
8. Teissie J, Golzio M, Rols MP: Mechanisms of cell membrane electropermeabilization: a minireview of our present (lack of?) knowledge. Biochim. Biophys. Acta1724, 270-280 (2005).
9. Wells DJ: Gene therapy progress and prospects: electroporation and other physical methods. Gene Ther. 11, 1363-1369 (2004).
10. Somiari S, Glasspool-Malone J, Drabick JJ et al.: Theory and in vivo application of electroporative gene delivery. Mol. Ther. 2, 178-187 (2000).
11. Tsong TY: Electroporation of cell membranes. Biophys. J. 60, 297-306 (1991).
12. Hendrie PC, Russell DW: Gene targeting with viral vectors. Mol. Ther. 12, 9-17 (2005).
13. Burton EA, Fink DJ, Glorioso JC: Gene delivery using herpes simplex virus vectors. DNA Cell Biol. 21, 915-936 (2002).
14. Advani SJ, Weichselbaum RR, Whitley RJ, Roizman B: Friendly fire: redirecting herpes simplex virus-1 for therapeutic applications. Clin. Microbiol. Infect. 8, 551-563 (2002).
15. Yeh P, Perricaudet M: Advances in adenoviral vectors: from genetic engineering to their biology. FASEB J 11, 615-623 (1997).
16. Ledley FD: Nonviral gene therapy - the promise of genes as pharmaceutical products. Hum. Gene Ther. 6, 1129-1144 (1995).
17. Flotte TR, Carter BJ: Adeno-associated virus vectors for gene therapy. Gene Ther. 2, 357-362 (1995).
18. Campbell EM, Hope TJ: Gene therapy progress and prospects: viral trafficking during infection. Gene Ther. 12, 1353-1359 (2005).
19. Gene Therapy Clinical Trials Worldwide. J. Gene Med. (2007).
20. Peng ZH: Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers. Hum. Gene Ther. 16, 1016-1027 (2005).
21. Walsh G: Biopharmaceutical benchmarks 2006. Nat. Biotechnol. 24, 769-776 (2006).
22. Guo J, Xin H: Chinese gene therapy - splicing out the west? Science 314, 1232-1235 (2006).
23. Tatsis N, Ertl HCJ: Adenoviruses as vaccine vectors. Mol. Ther. 10, 616-629 (2004).
24. Muruve DA: The innate immune response to adenovirus vectors. Hum. Gene Ther. 15, 1157-1166 (2004).
25. Niidome T, Huang L: Gene therapy progress and prospects: nonviral vectors. Gene Ther. 9, 1647-1652 (2002).
26. Godbey WT, Barry MA. Saggau P, Wu KK, Mikos AG: Poly(ethylenimine)-mediated transfection: a new paradigm for gene delivery. J. Biomed. Mat. Res. 51, 321-328 (2000).
27. Remy Kristensen A, Clamme JP, Vuilleumier C, Kuhry JG, Mely Y: Role of endocytosis in the transfection of L929 fibroblasts by polyethylenimine/ DNA complexes. Biochim. Biophys. Acta 1514, 21-32 (2001).
28. Varga CM, Tedford NC, Thomas M, Klibanov AM, Griffith LG, Lauffenburger DA: Quantitative comparison of polyethylenimine formulations and adenoviral vectors in terms of intracellular gene delivery processes. Gene Ther. 12, 1023-1032 (2005).
29. Nishikawa M, Huang L: Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum. Gene Ther. 12. 861-870 (2001).
30. De Smedt SC, Remaut K, Lucas B, Braeckmans K, Sanders NN, Demeester J: Studying biophysical barriers to DNA delivery by advanced light microscopy. Adv. Drug Deliv. Rev. 57, 191-210 (2005).
31. Torchilln VP: Fluorescence microscopy to follow the targeting of liposomes and micelles to cells and their intracellular fate. Adv Drug Deliv. Rev. 57,95-109 (2005).
32. Rao NM, Gopal V: Cell biological and biophysical aspects of lipid-mediated gene delivery. Biosci. Rep. 26, 301-324 (2006).
33. Payne CK, Jones SA, Chen C, Zhuang XW: Internalization and trafficking of cell surface proteoglycans and proteoglycan-binding ligands. Traffic 8, 389-401 (2007).
34. Godbey WT, Wu KK, Mikos AG: Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc. Natl Acad Sci. USA 96, 5177-5181 (1999).
35. Forrest ML, Gabrielson N, Pack DW: Cycloclextrin-polyethylenimine conjugates for targeted in vitro gene delivery. Biotechnol. Bioeng. 89, 416-423 (2005).
36. Park TC, Jeong JH, Kim SW: Current status of polymeric gene delivery systems. Adv. Drug Deliv. Rev. 58, 467-486 (2006).
37. Putnam D: Polymers for gene delivery across length scales. Nat. Mater. 5, 439-451 (2006).
38. Niculescu-Duvaz D, Heyes J. Springer CJ: Structure-activity relationship in cationic lipid mediated gene transfection. Curr. Med. Chem. 10, 1233-1261 (2003).
39. Mahato RI: Water insoluble and soluble lipids for gene delivery. Adv. Drug Deliv. Rev. 57, 699-712 (2005).
40. Martin B, Sainlos M, Aissaoui A et al.: The design of cationic lipids for gene delivery. Curr. Pharm. Des. 11, 375-394 (2005).
41. Chauhan A, Tikoo A, Kapur AK, Singh M: The taming of the cell penetrating domain of the HIV Tat: myths and realities. J. Control. Release 117, 148-162 (2007).
42. Fabre JW, Collins L: Synthetic peptides as non-viral DNA vectors. Curr Gene Ther. 6, 459-480 (2006).
43. Lechardeur D. Verkman AS. Lukacs GL: Intracellular routing of plasmid DNA during non-viral gene transfer. Adv Drug Deliv Rev. 57, 755-767 (2005).
44. Mediria-Kauwe LK, Xie J, Hamm-Alvarez S: Intracellular trafficking of nonviral vectors. Gene Ther. 12, 1734-1751 (2005).
45. Suh J, Dawson M, Hanes J: Real-time multiple-particle tracking: applications to drug and gene delivery. Adv. Drug Deliv. Rev. 57, 63-78 (2005).
46. Belting M, Sandgren S, Wittrup A: Nuclear delivery of macromolecules: barriers and carriers. Adv. Drug Deliv. Rev. 57, 505-527 (2005).
47. Wightman L, Kircheis R, Rössler V et al.: Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo. J. Gene Med. 3, 362-372 (2001).
48. Choosakoonkriang S, Lobo BA, Koe GS. Koe JG, Middaugh CR: Biophysical characterization of PEI/DNA complexes. J. Pharm. Sci. 92, 1710-1722 (2003).
49. Han J, Kim SK, Cho TS, Lee JC, Joung HS: Polyplex formation of calf thymus DNA with branched and linear polyethyleneimine. Macro. Res. 12,501-506 (2004).
50. Bertschinger M, Backliwal G, Schertenleib A, Jordan M, Hacker DL, Wurm FM: Disassembly of polyethylenimine-DNA.particles in vitro: Implications for polyethylenimine-mediated DNA delivery. J. Control. Release 116, 96-104 (2006).
51. Seib FP, Jones AT, Duncan R: Comparison of the endocytic properties of linear and branched PEIs, and cationic PAMAM dendrimers in B16f10 melanoma cells. J. Control. Release 117, 291-300 (2007).
52. Jeong GJ, Byun HM, Kim JM et al.: Biodistribution and tissue expression kinetics of plasmid DNA complexed with polyethylenimines of different molecular weight and structure. J. Control. Release 118, 118-125 (2007).
53. Blessing T, Kursa M, Holzhauser R, Kircheis R, Wagner E: Different strategies for formation of PECylated EGF-conjugated PEI/DNA complexes for targeted gene delivery. Bioconj. Chem. 12, 529-537 (2001).
54. Brock R, Hink MA, Jovin TM: Fluorescence correlation microscopy of cells in the presence of autofluorescence. Biophys. J. 75, 2547-2557 (1998).
55. Merdan T, Kunath K, Petersen H et al.: PEGylation of poly(ethylene imine) affects stability of complexes with plasmid DNA under in vivo conditions in a dose-dependent manner after intravenous injection into mice. Bioconj. Chem. 16, 785-792 (2005).
56. Mislick KA, Baldeschwieler JD: Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc. Natl Acad. Sci. USA 93, 12349-12354 (1996).
57. Sandgren S, Wittrup, A, Cheng F et al.: The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent enclocytosis. J. Biol. Chem. 279, 17951-17956 (2004).
58. Fuchs SM, Raines RT. Pathway for polyarginine entry into mammalian cell. Biochemistry 43, 2438-2444 (2004).
59. Bausinger R, von Gersdorff K, Braeckmans K et al.: The transport of nanosized gene carriers unraveled by live-cell imaging. Angew. Chem. Int. Ed. Engl. 45, 1568-1572 (2006).
60. Kopatz I, Remy JS, Behr JP: A model for non-viral gene delivery: through syndecan adhesion molecules and powered by actin. J. Gene Med. 6, 769-76 (2004).
61. Futaki S: Membrane-permeable arginine-rich peptides and the translocation mechanisms. Adv. Drug Deliv. Rev. 57, 547-558 (2005).
62. El-Andaloussi S, Holm T, Langel U: Cell-penetrating peptides: mechanisms and applications. Curr. Pharm. Des. 11, 3597-3611 (2005).
63. Wang YH, Chen CP, Chan MH et al.: Arginine-rich intracellular delivery peptides noncovalently transport protein into living cells. Biochem. Biophys. Res. Commun. 346, 758-767 (2006).
64. Wolf Y, Pritz S, Abes S, Bienert M, Lebleu B, Oehlke J: Structural requirements for cellular uptake and antisense activity of peptide nuclelc acids conjugated with various peptides. Biochemistry 45, 14944-14954 (2006).
65. Veldhoen S, Laufer SD, Trampe A, Restle T: Cellular delivery of small interfering RNA by a non-covalently attached cell-penetrating peptide: quantitative analysis of uptake and biological effect. Nucleic Acids Res. 34, 6561-6573 (2006).
66. Boussif O, Lezoualc'h E Zanta MA et al.: A versatile vector for gene and oligonucleotide transfer Into cells in culture and in vivo. polyethylenimine. Proc. Natl Acad. Scl. USA 92, 7297-301 (1995).
67. Belting M: Heparan sulfate proteoglycan as a plasma membrane carrier. Trends Biochem, Sci. 28. 145-151 (2003)
68. Belting M, Persson S, Fransson LA: Proteoglycan involvement in polyamine uptake. Biochem. J. 338, 317-323 (1999).
69. Conner SD, Schmid SL: Regulated portals' of entry into the cell. Nature 422, 37-44 (2003).
70. Norkin LC: Caveolae in the uptake and targeting of infectious agents and secreted toxins. Adv. Drug Deliv. Rev. 49, 301-315 (2001).
71. Nabi IR, Le PU: Caveolae/raft-dependent endocytosis. J. Cell Biol. 161, 673-677 (2003).
72. Kirkham M, Fujita A, Chadda R et al.: Ultrastructural identification of uncoated caveolin-independent early endocytic vehicles. J. Cell Biol. 168, 465-476 (2005).
73. Glebov OO, Bright NA, Nichols BJ: Flotillin-1 defines a clathrin-independent endocytic pathway in mammalian cells. Nat. Cell Biol. 8, 46-54 (2006).
74. von Gersdorff K, Sanders NN, Vandenbroucke R, De Smedt SC, Wagner E, Ogris M: The internalization route resulting in successful-gene expression depends on both cell line and polyethylenimine polyplex type. Mol. Ther. 14, 745-753 (2006).
75. Rejman J, Bragonzi A, Conese M:, Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes. Mol. Ther. 12, 468-474 (2005).
76. Rejman J, Conese M, Hoekstra D: Gene transfer by means of lipo- and polyplexes: role of clathrin and caveolae-mediated endocytosis. J. Lipasome Res. 16. 237-247 (2006).
77. Grosse S, Thevenot G, Monsigny M, Fajac I: Which mechanism for nuclear import of plasmid DNA complexed with polyethylenimine derivatives? J. Gene Med. 8, 845-851 (2006).
78. Suh JH, Wirtz D, Hanes J: Real-time intracellular transport of gene nanocarriers studied by multiple particle tracking. Biotechnol. Prog. 20, 598-602 (2004).
79. Kulkarni RP, Mishra S, Fraser SE, Davis ME: Single cell kinetics of intracellular, nonviral, nucleic acid delivery vehicle acidification and trafficking. Bioconj. Chem. 16, 986-994 (2005).
80. Suk JS, Sub J, Lai SK, Hanes J: Quantifying the intracellular transport of viral and nonviral gene vectors in primary neurons. Exp. Biol. Med. 232, 461-469 (2007).
81. Suh J, Wirtz D, Hanes J: Efficient active transport of gene nanocarriers to the cell nucleus. Proc. Natl Acad Sci. USA 100, 3878-3882 (2003).
82. Nan XL, Sims PA, Chen P, Xie XS: Observation of individual microtubule motor steps in living cells with endocytosed quantum dots. J. Phys. Cbem. B 109, 24220-24224 (2005).
83. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson J: Molecular biology of the cell. Garland Publishing, New York, USA (1994).
84. Pelkmans L: Secrets of caveolae- and lipid raft-mediated endocytosis revealed by mammalian viruses. Biochim. Biophys. Acta 1746, 295-304 (2005).
85. Sonawane ND, Szoka FC, Verkman AS: Chloride accumulation and swelling in endosomet enhances DNA transfer by polyamine-DNA polyplexes. J. Biol. Chem. 278, 44826-44831 (2003).
86. Clamme JP, Krishnamoorthy G, Mely Y: Intracellular dynamics of the gene delivery vehicle polyethylenimine during transfection: investigation by two-photon fluorescence correlation spectroscopy. Biochim. Biophys. Acta 1617, 52-61 (2003).
87. Klemm AR, Young D, Lloyd JB: Effects of polyethyleneimine on endocytosis and lysosome stability. Biochem. Pharmacol. 56, 41-46 (1998).
88. Grosse S, Aron Y, Thevenot G, Francois D, Monsigny M. Fajac I: Potocytosis and cellular exit of complexes as cellular pathways for gene delivery by polycations. J. Gene Med. 7, 1275-1286 (2005).
89. Itaka K, Harada A, Yamasaki Y, Nakamura K, Kawaguchi H, Kataoka K: In situ single cell observation by fluorescence resonance energy transfer reveals fast intracytoplasmic delivery and easy release of plasmid DNA complexed with linear polyethylenimine. J. Gene Med. 6. 76-84 (2004).
90. Ho YP, Chen HH, Leong KW, Wang TH: Evaluating the intracellular stability and unpacking of DNA nanocomplexes by quantum dots-FRET. J. Control. Release 116, 83-89 (2006).
91. Thomas M, Klibanov AM: Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells. Proc. Natl Acad Sci. USA 99, 14640-14645 (2002).
92. Pack DW, Hoffman AS, Pun S, Stayton PS: Design and development of polymers for gene delivery. Nat. Rev. Drug Disc. 4, 581-593 (2005).
93. Kircheis R, Wightman L, Wagner E: Design and gene delivery activity of modified polyethylenimines, Adv. Drug Deliv. Rev. 53, 341-358 (2001).
94. Neu M, Fischer D, Kissel T: Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives. J. Gene Med. 7, 992-1009 (2005).
95. Forrest ML, Meister GE, Koerber JT, Pack DW: Partial acetylation of polyethylenimine enhances in vitro gene delivery. Pharm. Res. 21, 365-371 (2004).
96. Gabrielson NP, Pack DW: Acetylation of polyethylenimine enhances gene delivery via weakened polymer/DNA interactions. Biomacromolecules 7, 2427-2435 (2006).
97. Thomas M, Ge Q, Lu JJ, Chen JZ, Klibanov AM: Cross-linked small polyethylenimines: While still nontoxic, deliver DNA efficiently to mammalian cells in vitro and in vivo. Pharm. Res. 22, 373-380 (2005).
98. Thomas M, Klibanov AM: Conjugation to gold nanoparticles enhances polyethylenimine's transfer of plasmid DNA into mammalian cells. Proc. Natl Acad. Sci. USA 100, 9138-9143 (2003).
99. Kircheis R, Wightman L, Kursa M, Ostermarm E, Wagner E: Tumor-targeted gene delivery: an attractive strategy to use highly active effector molecules in cancer treatment. Gene Ther. 9, 731-735 (2002).
100. Kircheis R, Wightman L, Schreiber A et al.: Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application. Gene Ther. 8, 28-40 (2001).
101. Anderson DG, Akinc A, Hossain N, Langer R: Structure/property studies of polymeric gene delivery using a library of poly(β-amino esters). Mol. Ther. 11, 426-434 (2005).
102. Green JJ, Shi J. Chiu E, Leshchiner ES, Langer R, Anderson DG: Biodegradable polymeric vectors for gene delivery to human endothelial cells. Bioconj. Chem. 17, 1162-1169 (2006).
103. Zugates GT, Anderson DG, Little SR, Lawhorn IEB, Langer R: Synthesis of poly(β-amino ester)s with thiol-reactive side chains for DNA delivery. J. Am. Chem. Soc. 128, 12726-12734 (2006).
104. Thomas M, Lu JJ, Ge Q, Zhang C, Chen J, Klibanov AM: Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung. Proc. Natl Acad. Sci. USA 102, 5679-5684 (2005).
105. Zou SM, Erbacher P. Remy JS, Behr JP: Systemic linear polyethylenimine (L-PEI) - mediated gene delivery in the mouse. J. Gene Med. 2, 128-134 (2000).
106. Kural C, Serpinskaya AS, Chou YH, Goldman RD, Gelfand VI, Selvin PR: Tracking melanosomes inside a cell to study molecular motors and their interaction. Proc. Natl Acad. Sci. USA 104, 5378-5382 (2007).
107. Rink J, Ghigo E, Kalaidzidis Y, Zerial M: Rab conversion as a mechanism of progression from early to late endosomes. Cell 122, 735-749 (2005).
108. Lakadamyali M, Rust MJ, Zhuang X: Ligands for clathrin-mediated endocytosis are differentially sorted into distinct populations of early endosomes. Cell 124, 997-1009 (2006).
109. Tagawa A, Mezzacasa A, Hayer A, Longatti A, Pelkmans L, Helenius A: Assembly and trafficking of caveolar domains in the cell: caveolae as stable, cargo-triggered, vesicular transporters. J. Cell Biol. 170, 769-779 (2005).
110. Cang H, Wong CM, Xu CS. Rizvi AH, Yang H: Confocal three dimensional tracking of a single nanoparticle with concurrent spectroscopic readouts. Appl. Phys. Lett. 88 (2006).
111. Holtzer L, Meckel T, Schmidt T: Nanometric three-dimensional tracking of individual quantum dots in cells. Appl. Phys. Lett. 90 (2007).
112. Giepmans BNG, Adams SR, Ellisman MH, Tsien RY: Review - the fluorescent toolbox for assessing protein location and function. Science 312, 217-224 (2006).
113. Pinaud F, Michalet X, Bentolila LA et al.: Advances in fluorescence imaging with quantum dot bio-probes. Biomaterials 27, 1679-1687 (2006).
114. Zheng J, Zhang CW, Dickson RM: Highly fluorescent, water-soluble, size-tunable gold quantum dots. Phys. Rev. Lett. 93 (2004).
115. Hess ST. Girirajan TPK, Mason MD: Ultra-high resolution imaging by fluorescence photoactivation localization microscopy. Biophys. J. 91, 4258-4272 (2006).
116. Betzig E, Patterson GH, Sougrat R et al.: Imaging intracellular fluorescent proteins at nanometer resolution. Science 313, 1642-1645 (2006).
117. Rust MJ, Bates M, Zhuang XW: Sub-diffraction-limit imaging by stochastic optical reconstruction microscopy (STORM). Nat. Methods 3, 793-795 (2006).
118. Brandenburg B, Zhuang XW: Virus trafficking - learning from single-virus tracking. Nat. Rev. Microbiol. 5, 197-208 (2007).